The GelStix product is intended to treat chronic lower back pain which impacts nearly 10-15% of adults and is associated with a condition known as degenerative disc disease. GelStix received the CE Mark in early 2010 and is now available for sale and …
See original here:
Replication Medical Receives Grant of Nearly $250,000.00 on the Heels of Successful Clinical … – Melodika.net
